Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Dabirian, Sara ^a   Taslimi, Yasaman ^a   Zahedifard, Farnaz ^a   Gholami, Elham ^a   Doustdari, Fatemeh ^a   Motamedirad, Mahdieh ^a   Khatami, Shohreh ^a   Azadmanesh, Kayhan ^a   Nylen, Susanne ^b   Rafati, Sima ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CPG OLIGODEOXYNUCLEOTIDE; DEFENSIN; DEFENSIN 1; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL VIABILITY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; NECROSIS; NEUTROPHIL; NONHUMAN; PROMASTIGOTE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ALPHA-DEFENSINS; APOPTOSIS; CELLS, CULTURED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMMUNOLOGIC FACTORS; LEISHMANIA MAJOR; MALE; MIDDLE AGED; NEUTROPHILS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887282261     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002491     Document Type: Article

References (46)

1. de Leeuw E, Lu W, (2007) Human defensins: turning defense into offense? Infect Disord Drug Targets 7: 67-70.
2. McGwire BS, Kulkarni MM, (2010) Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism. Exp Parasitol 126: 397-405.
3. Cobb SL, Denny PW, (2010) Antimicrobial peptides for leishmaniasis. Curr Opin Investig Drugs 11: 868-875.
4. Kulkarni MM, McMaster WR, Kamysz W, McGwire BS, (2009) Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem 284: 15496-15504.
5. Ullal AJ, Noga EJ, (2010) Antiparasitic activity of the antimicrobial peptide HbbetaP-1, a member of the beta-haemoglobin peptide family. J Fish Dis 33: 657-664.
6. Ursic-Bedoya R, Buchhop J, Joy JB, Durvasula R, Lowenberger C, (2011) Prolixicin: a novel antimicrobial peptide isolated from Rhodnius prolixus with differential activity against bacteria and Trypanosoma cruzi. Insect Mol Biol 20: 775-786.
7. Madison MN, Kleshchenko YY, Nde PN, Simmons KJ, Lima MF, et al. (2007) Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Infect Immun 75: 4780-4791.
8. Tanaka T, Rahman MM, Battur B, Boldbaatar D, Liao M, et al. (2010) Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii. In Vitro Cell Dev Biol Anim 46: 560-565.
9. Mangoni ML, Saugar JM, Dellisanti M, Barra D, Simmaco M, et al. (2005) Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem 280: 984-990.
10. Huang L, Xu Z, Zhong Z, Peng L, Chen H, et al. (2007) Enhanced expression and primary purification of soluble HBD3 fusion protein in Escherichia coli. Appl Biochem Biotechnol 142: 139-147.
11. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J, (2007) Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 179: 3958-3965.
12. Harwig SS, Ganz T, Lehrer RI, (1994) Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol 236: 160-172.
13. Cowland JB, Borregaard N, (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 66: 989-995.
14. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, et al. (2007) alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis 196: 835-843.
15. Yang D, Chertov O, Oppenheim JJ, (2001) Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 69: 691-697.
16. Muller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, et al. (2001) Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol 190: 73-76.
17. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, et al. (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321: 970-974.
18. Nathan C, (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6: 173-182.
19. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, et al. (2006) Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci U S A 103: 13837-13842.
20. Agren J, Thiemermann C, Foster SJ, Wang JE, Aasen AO, (2006) Cytokine responses to CpG DNA in human leukocytes. Scand J Immunol 64: 61-68.
21. Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, et al. (2002) Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 169: 898-905.
22. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, et al. (2004) Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 173: 6521-6525.
23. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC, (2005) Human defensins. J Mol Med (Berl) 83: 587-595.
24. Safaiyan S, Bolhassani A, Nylen S, Akuffo H, Rafati S, (2011) Contribution of human neutrophils in the development of protective immune response during in vitro Leishmania major infection. Parasite Immunol 33: 609-620.
25. Sanz MJ, Jose PJ, Williams TJ, (2000) Measurement of eosinophil accumulation in vivo. Methods Mol Biol 138: 275-283.
26. Rehder DS, Borges CR, (2010) Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding. Biochemistry 49: 7748-7755.
27. Pazgier M, Lubkowski J, (2006) Expression and purification of recombinant human alpha-defensins in Escherichia coli. Protein Expr Purif 49: 1-8.
28. Chadbourne FL, Raleigh C, Ali HZ, Denny PW, Cobb SL, (2011) Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa. J Pept Sci 17: 751-755.
29. Prina E, Roux E, Mattei D, Milon G, (2007) Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microbes Infect 9: 1307-1315.
30. Welling MM, Hiemstra PS, van den Barselaar MT, Paulusma-Annema A, Nibbering PH, et al. (1998) Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest 102: 1583-1590.
31. Arnett E, Lehrer RI, Pratikhya P, Lu W, Seveau S, (2011) Defensins enable macrophages to inhibit the intracellular proliferation of Listeria monocytogenes. Cell Microbiol 13: 635-651.
32. Xu N, Wang YS, Pan WB, Xiao B, Wen YJ, et al. (2008) Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice. Mol Cancer Ther 7: 1588-1597.
33. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi AK, et al. (1997) CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 100: 68-73.
34. Weighardt H, Feterowski C, Veit M, Rump M, Wagner H, et al. (2000) Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol 165: 4537-4543.
35. Jozsef L, Khreiss T, El Kebir D, Filep JG, (2006) Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol 176: 1195-1202.
36. Martinson JA, Tenorio AR, Montoya CJ, Al-Harthi L, Gichinga CN, et al. (2007) Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology 120: 526-535.
37. Nagaoka I, Suzuki K, Murakami T, Niyonsaba F, Tamura H, et al. (2010) Evaluation of the effect of alpha-defensin human neutrophil peptides on neutrophil apoptosis. Int J Mol Med 26: 925-934.
38. Jozsef L, Khreiss T, Filep JG, (2004) CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J 18: 1776-1778.
39. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
40. Roberts TL, Dunn JA, Terry TD, Jennings MP, Hume DA, et al. (2005) Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 175: 3569-3576.
41. Cocco RE, Ucker DS, (2001) Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell 12: 919-930.
42. Laskay T, van Zandbergen G, Solbach W, (2003) Neutrophil granulocytes-Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol 11: 210-214.
43. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, DosReis GA, et al. (2008) Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol 84: 389-396.
44. Laufs H, Muller K, Fleischer J, Reiling N, Jahnke N, et al. (2002) Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect Immun 70: 826-835.
45. van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T, (2002) Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun 70: 4177-4184.
46. Bhowmick S, Mazumdar T, Ali N, (2009) Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect Immun 77: 1514-1523.